March 01, 2015 8:34 AM ET


Company Overview of AutoImmune Inc.

Company Overview

AutoImmune Inc. went out of business. AutoImmune Inc., a biopharmaceutical company, develops products for the treatment of autoimmune and cell-mediated inflammatory diseases and conditions. Its offers its pharmaceuticals under Colloral, The Collagen Solution, and Vital 3 brand names for treating the signs and symptoms of rheumatoid arthritis. The company’s products under development include MBP8298, for the treatment of secondary progressive multiple sclerosisand for relapsing-remitting multiple sclerosis; Oral Copaxone that is in preclinical stage for the treatment of multiple sclerosis; and AI 401, which is in Phase III clinical trials for the treatment of Type I diabetes. The company has ...

1199 Madia Street

Pasadena, CA 91103

United States

Founded in 1988





Key Executives for AutoImmune Inc.

AutoImmune Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Tepha, Inc. United States
Insmed Therapeutic Proteins, Inc. United States
TRG Biogenic LLC United States
Alkira Therapeutics, Inc. United States
Hemera Biosciences Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AutoImmune Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at